Peptides with dermatological evidence — ranked by human skin-biology research.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
The skin-peptide space is unusual because topical formulations have more controlled human research than injectable dermatological claims. GHK-Cu is the anchor compound with decades of cosmeceutical literature.
How we ranked: Ordered by: (1) human skin-biology evidence, (2) mechanism specificity, (3) cosmeceutical/clinical availability.
Copper-binding tripeptide with 50+ human studies covering collagen synthesis, skin elasticity, wound healing, and gene-expression normalization in aged skin. Standard ingredient in medical-grade topicals.
Preclinical data on wound-healing and angiogenesis translate plausibly to skin recovery contexts. Systemic effects on skin aging are unproven in humans.
Alpha-MSH analog that induces melanogenesis — used cosmetically for tanning. Carries documented cardiovascular, GI, and melanocytic-lesion safety signals; not FDA approved for any indication.
GHK-Cu has strong controlled human evidence for collagen synthesis, skin elasticity, and wrinkle markers in topical formulations. It is one of the most studied cosmeceutical peptides.
GHK-Cu has some topical-formulation data for hair-follicle support, but peptides are not FDA approved for androgenetic alopecia. Minoxidil and finasteride remain first-line evidence-based options.
No. Melanotan II is associated with changes to existing moles, new nevus formation, cardiovascular effects, and priapism. It is not FDA approved and is not recommended for cosmetic tanning.